Dow Down 0.02% Nasdaq Up 0.07%

Urologix, Inc. (ULGX)

-Other OTC
0.10 Up 0.00(4.44%) 10:27AM EST
Prev Close:0.10
Open:0.08
Bid:N/A
Ask:N/A
1y Target Est:1.50
Beta:-0.11
Earnings Date:Feb 2 - Feb 6 (Est.)
Day's Range:0.08 - 0.10
52wk Range:0.07 - 0.25
Volume:113,500
Avg Vol (3m):27,497
Market Cap:2.11M
P/E (ttm):N/A
EPS (ttm):-0.32
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
ULGXUp 4.44%2.11M
LMNSDown 0.20%360.26M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):0.15
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (0-00-31) :N/A
Quarterly EPS Est (0-00-31) :N/A
Mean Recommendation*:1.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Urologix, Inc. develops, manufactures, and markets non-surgical, office-based therapies for the treatment of the symptoms and obstruction resulting from benign prostatic hyperplasia (BPH). View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback